EyePoint (EYPT) Gross Profit (2018 - 2026)

EyePoint (EYPT) posted Gross Profit of $168000.0 for Q1 2026, down 31.43% sequentially from $245000.0 in Q4 2025, and down 99.29% YoY from $23.6 million in Q1 2025.

EyePoint (EYPT) Gross Profit (2018 - 2026) Analysis & Trends

EyePoint has reported Gross Profit for 9 years, with the latest figure at $168000.0 in Q1 2026.

  • Quarterly Gross Profit fell 99.29% year-over-year to $168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 88.86% YoY) and the FY2025 annual result came in at $29.3 million, down 25.92% from the prior year.
  • Gross Profit slipped to $168000.0 in Q1 2026 per EYPT's latest filing, from $245000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $23.6 million in Q1 2025 and troughed at $168000.0 in Q1 2026.
  • A 5-year average of $8.4 million and a median of $8.1 million in 2024 frame the typical range for Gross Profit.
  • The sharpest annual moves came in 2025 and 2026: Gross Profit soared 116.46% in 2025, then sank 99.29% in 2026.
  • Over 5 years, Gross Profit stood at $7.1 million in 2022, then surged by 82.93% to $13.0 million in 2023, then slipped by 17.33% to $10.8 million in 2024, then tumbled by 97.73% to $245000.0 in 2025, then plunged by 31.43% to $168000.0 in 2026.
  • According to Business Quant data, Gross Profit over the past three periods registered $168000.0, $245000.0, and $245000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 EyePoint 1.25 Bn 1.07 Bn 507,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 507,000.00
Jun 30, 2026 507,000.00
Mar 31, 2026 168,000.00
Mar 31, 2026 168,000.00
Dec 31, 2025 245,000.00
Dec 31, 2025 245,000.00
Sep 30, 2025 245,000.00
Sep 30, 2025 245,000.00
Jun 30, 2025 5.17 Mn
Jun 30, 2025 5.17 Mn
Mar 31, 2025 23.65 Mn
Mar 31, 2025 23.65 Mn
Dec 31, 2024 10.77 Mn
Dec 31, 2024 10.77 Mn
Sep 30, 2024 9.79 Mn
Sep 30, 2024 9.79 Mn
Jun 30, 2024 8.08 Mn
Jun 30, 2024 8.08 Mn
Mar 31, 2024 10.93 Mn
Mar 31, 2024 10.93 Mn